Medifast at $22..

Still sliding steadily more or less in a straight line. Down another tenth to $l9.70.

It would appear that the market's assumptions are
* Everybody will be on semaglutide type drugs and nobody will ever be interested in anything else related to weight control
* MED will never make a buck from this type of drug
* None of their other initiatives will ever make money

Those might all be right, but sometimes a narrative is taken too far. Beats me.

"Analyst consensus" for 2025 is EPS of $1.56. The current price is 12.6 times that. In fact, if that future earnings figure is correct, current prices do not look unreasonably low. To be bullish, you have to think earnings will stabilize at a level than these folks expect.

Jim
(no position, just enjoying watching the chart unfold)

Falling Knives FAQ

---

Contact Shrewd'm
Contact the developer of these message boards.